The Life Pulse high frequency jet ventilator has experienced its second consecutive year of 25% sales growth. Analysis of customer data seems to indicate an increased use of this high frequency modality in clinical care. Bunnell, Inc. believes that HFJV is becoming the treatment of choice for infants for whom other forms of ventilation have failed. (Photo: J. Bert Bunnell, Chairman and Chief Technical Officer)